Works matching IS 00071048 AND DT 2007 AND VI 136 AND IP 3


Results: 23
    1
    2
    3

    Molecular therapies in β-thalassaemia.

    Published in:
    British Journal of Haematology, 2007, v. 136, n. 3, p. 353, doi. 10.1111/j.1365-2141.2006.06408.x
    By:
    • Quek, Lynn;
    • Swee Lay Thein
    Publication type:
    Article
    4
    5
    6
    7
    8

    Complete response in myeloma extends survival without, but not with history of prior monoclonal gammopathy of undetermined significance or smouldering disease.

    Published in:
    British Journal of Haematology, 2007, v. 136, n. 3, p. 393, doi. 10.1111/j.1365-2141.2006.06441.x
    By:
    • Pineda-Roman, Mauricio;
    • Bolejack, Vanessa;
    • Arzoumanian, Varant;
    • Anaissie, Elias;
    • van Rhee, Frits;
    • Zangari, Maurizio;
    • Walker, Ron;
    • Hollmig, Klaus;
    • Shaughnessy, John D.;
    • Epstein, Joshua;
    • Krishna, Somashekar;
    • Crowley, John;
    • Barlogie, Bart
    Publication type:
    Article
    9
    10
    12

    BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen-activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth.

    Published in:
    British Journal of Haematology, 2007, v. 136, n. 3, p. 414, doi. 10.1111/j.1365-2141.2006.06443.x
    By:
    • Yasui, Hiroshi;
    • Hideshima, Teru;
    • Ikeda, Hiroshi;
    • Jin, Janice;
    • Ocio, Enrique M.;
    • Kiziltepe, Tanyel;
    • Okawa, Yutaka;
    • Vallet, Sonia;
    • Podar, Klaus;
    • Ishitsuka, Kenji;
    • Richardson, Paul G.;
    • Pargellis, Chris;
    • Moss, Neil;
    • Raje, Noopur;
    • Anderson, Kenneth C.
    Publication type:
    Article
    13
    14
    15

    A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease.

    Published in:
    British Journal of Haematology, 2007, v. 136, n. 3, p. 501, doi. 10.1111/j.1365-2141.2006.06455.x
    By:
    • Vichinsky, Elliott;
    • Onyekwere, Onyinye;
    • Porter, John;
    • Swerdlow, Paul;
    • Eckman, James;
    • Lane, Peter;
    • Files, Beatrice;
    • Hassell, Kathryn;
    • Kelly, Patrick;
    • Wilson, Felicia;
    • Bernaudin, Françoise;
    • Forni, Gian Luca;
    • Okpala, Iheanyi;
    • Ressayre-Djaffer, Catherine;
    • Alberti, Daniele;
    • Holland, Jaymes;
    • Marks, Peter;
    • Fung, Ellen;
    • Fischer, Roland;
    • Mueller, Brigitta U.
    Publication type:
    Article
    16
    17

    Activated platelet-derived microparticles in thalassaemia.

    Published in:
    British Journal of Haematology, 2007, v. 136, n. 3, p. 462, doi. 10.1111/j.1365-2141.2006.06449.x
    By:
    • Pattanapanyasat, Kovit;
    • Gonwong, Siriphan;
    • Chaichompoo, Porntip;
    • Noulsri, Egarit;
    • Lerdwana, Surada;
    • Sukapirom, Kasama;
    • Siritanaratkul, Noppadol;
    • Fucharoen, Suthat
    Publication type:
    Article
    18
    19
    20

    Phase II trial of denileukin diftitox for relapsed/refractory T-cell non-Hodgkin lymphoma.

    Published in:
    British Journal of Haematology, 2007, v. 136, n. 3, p. 439, doi. 10.1111/j.1365-2141.2006.06457.x
    By:
    • Dang, Nam H.;
    • Pro, Barbara;
    • Hagemeister, Fredrick B.;
    • Samaniego, Felipe;
    • Jones, Dan;
    • Samuels, Barry I.;
    • Rodriguez, Maria A.;
    • Goy, Andre;
    • Romaguera, Jorge E.;
    • McLaughlin, Peter;
    • Tong, Ann T.;
    • Turturro, Francesco;
    • Walker, Pamela L.;
    • Fayad, Luis
    Publication type:
    Article
    21
    22
    23